Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Van Hoydonck

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Revue Medicale De Bruxelles|February 14, 2015
[Ultrasonography and rheumatology]M J Fernandez-Lopez, S Verlinden, M Van Hoydonck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2011
Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesisA Lintermans, B Van Calster, M Van Hoydonck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 2012
Prospective study to assess fluid accumulation and tenosynovial changes in the aromatase inhibitor-induced musculoskeletal syndrome: 2-year follow-up dataA Lintermans, A Laenen, B Van Calster, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Revue Medicale De Bruxelles|February 14, 2015
[Ultrasonography and rheumatology]M J Fernandez-Lopez, S Verlinden, M Van Hoydonck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2011
Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesisA Lintermans, B Van Calster, M Van Hoydonck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 2012
Prospective study to assess fluid accumulation and tenosynovial changes in the aromatase inhibitor-induced musculoskeletal syndrome: 2-year follow-up dataA Lintermans, A Laenen, B Van Calster, et al.
Pageof 1